Showing 1,421 - 1,440 results of 27,284 for search '(( 50 ((ng decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 0.86s Refine Results
  1. 1421
  2. 1422
  3. 1423

    Expanding Three-Coordinate Gold(I) Anticancer Agent Chemical Space by Charles E. Greif (21728091)

    Published 2025
    “…We report the synthesis and characterization of 14 complexes of the type (Au(R)[N̂N])<sup>+</sup>, where R = tunable biaryldialkyl phosphine ligands and [N̂N] = bidentate phenanthroline derivatives as anticancer agents. …”
  4. 1424
  5. 1425
  6. 1426

    S2 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  7. 1427

    S1 File - by Yosuke Kameno (342665)

    Published 2023
    “…This initial increase and subsequent decrease in K6 and FCV-19S were more prominent in individuals with high trait anxiety (K6: B = 1.55, 95% CI = 1.18 to 1.91; FCV-19S: B = 4.27, 95% CI = 2.50 to 6.04) and in occupations other than physicians or nurses. …”
  8. 1428
  9. 1429
  10. 1430
  11. 1431

    Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum by Xin You (784189)

    Published 2018
    “…Compared with N-linked glycoproteins, the serum O-linked glycoproteins are not well-studied due to their high heterogeneity and their low abundance. Herein, we presented a novel chemoenzymatic method to analyze core-1 type of O-GalNAcylation in human serum. …”
  12. 1432

    Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum by Xin You (784189)

    Published 2018
    “…Compared with N-linked glycoproteins, the serum O-linked glycoproteins are not well-studied due to their high heterogeneity and their low abundance. Herein, we presented a novel chemoenzymatic method to analyze core-1 type of O-GalNAcylation in human serum. …”
  13. 1433

    Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum by Xin You (784189)

    Published 2018
    “…Compared with N-linked glycoproteins, the serum O-linked glycoproteins are not well-studied due to their high heterogeneity and their low abundance. Herein, we presented a novel chemoenzymatic method to analyze core-1 type of O-GalNAcylation in human serum. …”
  14. 1434

    Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum by Xin You (784189)

    Published 2018
    “…Compared with N-linked glycoproteins, the serum O-linked glycoproteins are not well-studied due to their high heterogeneity and their low abundance. Herein, we presented a novel chemoenzymatic method to analyze core-1 type of O-GalNAcylation in human serum. …”
  15. 1435

    Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum by Xin You (784189)

    Published 2018
    “…Compared with N-linked glycoproteins, the serum O-linked glycoproteins are not well-studied due to their high heterogeneity and their low abundance. Herein, we presented a novel chemoenzymatic method to analyze core-1 type of O-GalNAcylation in human serum. …”
  16. 1436

    Chemoenzymatic Approach for the Proteomics Analysis of Mucin-Type Core‑1 O‑Glycosylation in Human Serum by Xin You (784189)

    Published 2018
    “…Compared with N-linked glycoproteins, the serum O-linked glycoproteins are not well-studied due to their high heterogeneity and their low abundance. Herein, we presented a novel chemoenzymatic method to analyze core-1 type of O-GalNAcylation in human serum. …”
  17. 1437
  18. 1438
  19. 1439
  20. 1440

    Heteroplasmy evolution of cybrid clone V_50. by Anton K. Raap (109844)

    Published 2012
    “…<p>(A) Average cellular mutation load decreases with increasing passage number of clone V_50. …”